DK3190113T3 - Pyrrolopyrimidinforbindelser anvendt som tlr7-agonist - Google Patents
Pyrrolopyrimidinforbindelser anvendt som tlr7-agonist Download PDFInfo
- Publication number
- DK3190113T3 DK3190113T3 DK15831451.8T DK15831451T DK3190113T3 DK 3190113 T3 DK3190113 T3 DK 3190113T3 DK 15831451 T DK15831451 T DK 15831451T DK 3190113 T3 DK3190113 T3 DK 3190113T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds used
- tlr7 agonist
- pyrrolopyrimidine compounds
- pyrrolopyrimidine
- tlr7
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410405136.0A CN105367576A (zh) | 2014-08-15 | 2014-08-15 | 作为tlr7激动剂的吡咯并嘧啶化合物 |
CN201510392499 | 2015-07-06 | ||
PCT/CN2015/086909 WO2016023511A1 (zh) | 2014-08-15 | 2015-08-14 | 作为tlr7激动剂的吡咯并嘧啶化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3190113T3 true DK3190113T3 (da) | 2021-06-07 |
Family
ID=55303885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK15831451.8T DK3190113T3 (da) | 2014-08-15 | 2015-08-14 | Pyrrolopyrimidinforbindelser anvendt som tlr7-agonist |
Country Status (26)
Country | Link |
---|---|
US (2) | US9962388B2 (da) |
EP (1) | EP3190113B1 (da) |
JP (2) | JP6328341B2 (da) |
KR (2) | KR20190098277A (da) |
CN (4) | CN106661034B (da) |
AU (3) | AU2015303558B2 (da) |
BR (1) | BR112017002811B1 (da) |
CA (1) | CA2958097C (da) |
CL (1) | CL2017000379A1 (da) |
DK (1) | DK3190113T3 (da) |
EA (1) | EA032824B1 (da) |
ES (1) | ES2875313T3 (da) |
HR (1) | HRP20210927T1 (da) |
HU (1) | HUE054672T2 (da) |
IL (2) | IL250586B (da) |
LT (1) | LT3190113T (da) |
MX (1) | MX2017002028A (da) |
MY (1) | MY190026A (da) |
PH (2) | PH12017500281A1 (da) |
PL (1) | PL3190113T3 (da) |
PT (1) | PT3190113T (da) |
SG (2) | SG11201701169XA (da) |
SI (1) | SI3190113T1 (da) |
UA (1) | UA117634C2 (da) |
WO (1) | WO2016023511A1 (da) |
ZA (1) | ZA201803736B (da) |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2785551T3 (es) | 2014-06-30 | 2020-10-07 | Glykos Finland Oy | Derivado de sacárido de una carga útil tóxica y sus conjugados con anticuerpos |
CN106661034B (zh) * | 2014-08-15 | 2019-11-29 | 正大天晴药业集团股份有限公司 | 作为tlr7激动剂的吡咯并嘧啶化合物 |
MY182353A (en) | 2015-05-08 | 2021-01-20 | Hoffmann La Roche | Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection |
MA44334A (fr) | 2015-10-29 | 2018-09-05 | Novartis Ag | Conjugués d'anticorps comprenant un agoniste du récepteur de type toll |
HUE052770T2 (hu) * | 2015-11-05 | 2021-05-28 | Chia Tai Tianqing Pharmaceutical Group Co Ltd | 7-(Tiazol-5-il)pirrolopirimidin vegyület mint TLR7 agonista |
CN107043380A (zh) * | 2016-02-05 | 2017-08-15 | 正大天晴药业集团股份有限公司 | 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途 |
CN107043377A (zh) | 2016-02-05 | 2017-08-15 | 正大天晴药业集团股份有限公司 | 一种tlr7激动剂的三氟乙酸盐、晶型b及其制备方法、药物组合物和用途 |
CN107043378A (zh) * | 2016-02-05 | 2017-08-15 | 正大天晴药业集团股份有限公司 | 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体 |
CN107043379A (zh) * | 2016-02-05 | 2017-08-15 | 正大天晴药业集团股份有限公司 | 一种tlr7激动剂的晶型a、其制备方法和医药用途 |
JP2019525947A (ja) | 2016-06-01 | 2019-09-12 | エムスリー・バイオテクノロジー・インコーポレイテッドM3 Biotechnology, Inc. | 化合物 |
JOP20190024A1 (ar) | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | مركبات بيروليزين بها استبدال واستخداماتها |
CN109641904B (zh) | 2016-08-29 | 2022-01-28 | 豪夫迈·罗氏有限公司 | 用于治疗和预防病毒感染的7-取代的磺亚氨酰基嘌呤酮化合物 |
PT3510033T (pt) | 2016-09-09 | 2022-02-18 | Novartis Ag | Compostos e composições como inibidores de recetores endossomais do tipo toll |
EP3970750A1 (en) | 2016-09-13 | 2022-03-23 | F. Hoffmann-La Roche AG | Combined treatment with a tlr7 agonist and an hbv capsid assembly inhibitor |
PE20191353A1 (es) | 2016-10-14 | 2019-10-01 | Prec Biosciences Inc | Meganucleasas disenadas especificamente para el reconocimiento de secuencias en el genoma del virus de la hepatitis b |
WO2018078149A1 (en) * | 2016-10-31 | 2018-05-03 | F. Hoffmann-La Roche Ag | Novel cyclicsulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection |
EP3539963A4 (en) | 2016-11-11 | 2020-05-13 | Hepo Pharmaceutical Co., Ltd. | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE |
WO2018095426A1 (zh) * | 2016-11-28 | 2018-05-31 | 江苏恒瑞医药股份有限公司 | 吡唑并杂芳基类衍生物、其制备方法及其在医药上的应用 |
TW201900647A (zh) * | 2017-05-18 | 2019-01-01 | 大陸商江蘇恒瑞醫藥股份有限公司 | 雜芳基并吡唑類衍生物、其製備方法及其在醫藥上的應用 |
US10487084B2 (en) | 2017-08-16 | 2019-11-26 | Bristol-Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses therefor |
US10508115B2 (en) | 2017-08-16 | 2019-12-17 | Bristol-Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having heteroatom-linked aromatic moieties, conjugates thereof, and methods and uses therefor |
US10472361B2 (en) | 2017-08-16 | 2019-11-12 | Bristol-Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having a benzotriazole moiety, conjugates thereof, and methods and uses therefor |
US10457681B2 (en) | 2017-08-16 | 2019-10-29 | Bristol_Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor |
US10494370B2 (en) | 2017-08-16 | 2019-12-03 | Bristol-Myers Squibb Company | Toll-like receptor 7 (TLR7) agonists having a pyridine or pyrazine moiety, conjugates thereof, and methods and uses therefor |
KR20200086709A (ko) | 2017-11-14 | 2020-07-17 | 브리스톨-마이어스 스큅 컴퍼니 | 치환된 인돌 화합물 |
SI3728252T1 (sl) | 2017-12-18 | 2023-11-30 | Bristol-Myers Squibb Company | 4-azaindolne spojine |
CN111511730B (zh) | 2017-12-19 | 2023-07-25 | 百时美施贵宝公司 | 可用作tlr抑制剂的被酰胺取代的吲哚化合物 |
KR20200101402A (ko) | 2017-12-19 | 2020-08-27 | 브리스톨-마이어스 스큅 컴퍼니 | Tlr 억제제로서 유용한 치환된 인돌 화합물 |
AU2018390543A1 (en) * | 2017-12-19 | 2020-08-06 | Bristol-Myers Squibb Company | 6-azaindole compounds |
KR20200101399A (ko) | 2017-12-20 | 2020-08-27 | 브리스톨-마이어스 스큅 컴퍼니 | Tlr 억제제로서 유용한 아미노 인돌 화합물 |
CA3084582A1 (en) | 2017-12-20 | 2019-06-27 | Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. | 2'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein |
WO2019126083A1 (en) * | 2017-12-20 | 2019-06-27 | Bristol-Myers Squibb Company | Diazaindole compounds |
SG11202005695PA (en) | 2017-12-20 | 2020-07-29 | Bristol Myers Squibb Co | Aryl and heteroaryl substituted indole compounds |
AU2018392213B2 (en) | 2017-12-20 | 2021-03-04 | Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. | 3'3' cyclic dinucleotides with phosphonate bond activating the STING adaptor protein |
EP3752505B1 (en) | 2018-02-12 | 2023-01-11 | F. Hoffmann-La Roche AG | Novel sulfone compounds and derivatives for the treatment and prophylaxis of virus infection |
PL3759109T3 (pl) | 2018-02-26 | 2024-03-04 | Gilead Sciences, Inc. | Podstawione związki pirolizyny jako inhibitory replikacji hbv |
US10870691B2 (en) | 2018-04-05 | 2020-12-22 | Gilead Sciences, Inc. | Antibodies and fragments thereof that bind hepatitis B virus protein X |
TW202005654A (zh) | 2018-04-06 | 2020-02-01 | 捷克科學院有機化學與生物化學研究所 | 2,2,─環二核苷酸 |
TWI818007B (zh) | 2018-04-06 | 2023-10-11 | 捷克科學院有機化學與生物化學研究所 | 2'3'-環二核苷酸 |
CN111954675A (zh) | 2018-04-06 | 2020-11-17 | 捷克共和国有机化学与生物化学研究所 | 3’3’-环二核苷酸 |
TW201945388A (zh) | 2018-04-12 | 2019-12-01 | 美商精密生物科學公司 | 對b型肝炎病毒基因體中之識別序列具有特異性之最佳化之經工程化巨核酸酶 |
WO2019209811A1 (en) | 2018-04-24 | 2019-10-31 | Bristol-Myers Squibb Company | Macrocyclic toll-like receptor 7 (tlr7) agonists |
WO2019211799A1 (en) | 2018-05-03 | 2019-11-07 | Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. | 2'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide |
US20210220362A1 (en) * | 2018-05-25 | 2021-07-22 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Tlr7 agonist and pharmaceutical combination thereof for treating lung cancer |
WO2020028097A1 (en) | 2018-08-01 | 2020-02-06 | Gilead Sciences, Inc. | Solid forms of (r)-11-(methoxymethyl)-12-(3-methoxypropoxy)-3,3-dimethyl-8-0x0-2,3,8,13b-tetrahydro-1h-pyrido[2,1-a]pyrrolo[1,2-c] phthalazine-7-c arboxylic acid |
US11554120B2 (en) | 2018-08-03 | 2023-01-17 | Bristol-Myers Squibb Company | 1H-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (TLR7) agonists and methods and uses therefor |
CA3116137A1 (en) * | 2018-10-12 | 2020-04-16 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Tlr7 agonist for treating colorectal cancer and pharmaceutical combination thereof |
TWI721623B (zh) | 2018-10-31 | 2021-03-11 | 美商基利科學股份有限公司 | 經取代之6-氮雜苯并咪唑化合物 |
CA3116347A1 (en) | 2018-10-31 | 2020-05-07 | Gilead Sciences, Inc. | Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity |
BR112021015577A2 (pt) | 2019-02-08 | 2021-10-05 | Research & Business Foundation Sungkyunkwan University | Complexo-colesterol agonista do receptor toll-like 7 ou 8 e uso do mesmo |
WO2020178768A1 (en) | 2019-03-07 | 2020-09-10 | Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. | 3'3'-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator |
CN113543851A (zh) | 2019-03-07 | 2021-10-22 | 捷克共和国有机化学与生物化学研究所 | 2’3’-环二核苷酸及其前药 |
KR20210137518A (ko) | 2019-03-07 | 2021-11-17 | 인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. | 3'3'-사이클릭 다이뉴클레오티드 및 이의 프로드럭 |
EP3937944A1 (en) * | 2019-03-15 | 2022-01-19 | Chia Tai Tianqing Pharmaceutical Group Co.,Ltd | Toll-like receptor agonists for use in the treatment of hepatitis b |
TWI751516B (zh) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
TWI751517B (zh) | 2019-04-17 | 2022-01-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
CN113543788B (zh) | 2019-04-23 | 2023-12-19 | 正大天晴药业集团股份有限公司 | 一种tlr7激动剂的固体药物组合物 |
EP3972695A1 (en) | 2019-05-23 | 2022-03-30 | Gilead Sciences, Inc. | Substituted exo-methylene-oxindoles which are hpk1/map4k1 inhibitors |
KR20220041838A (ko) | 2019-08-02 | 2022-04-01 | 베이진 엘티디 | Tlr8 작용제로서의 이미다조[2,1-f][1,2,4]트리아진-4-아민 유도체 |
EP4017476A1 (en) | 2019-08-19 | 2022-06-29 | Gilead Sciences, Inc. | Pharmaceutical formulations of tenofovir alafenamide |
US20230015906A1 (en) * | 2019-09-29 | 2023-01-19 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Drug combination containing tlr7 agonist |
AR120096A1 (es) | 2019-09-30 | 2022-02-02 | Gilead Sciences Inc | Vacunas para vhb y métodos de tratamiento de vhb |
US20230031465A1 (en) | 2019-12-06 | 2023-02-02 | Precision Biosciences, Inc. | Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genome |
WO2021154661A1 (en) | 2020-01-27 | 2021-08-05 | Bristol-Myers Squibb Company | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS |
US20230041738A1 (en) | 2020-01-27 | 2023-02-09 | Bristol-Myers Squibb Company | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS |
WO2021154662A1 (en) | 2020-01-27 | 2021-08-05 | Bristol-Myers Squibb Company | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS |
CN115279765A (zh) | 2020-01-27 | 2022-11-01 | 百时美施贵宝公司 | 作为Toll样受体7(TLR7)激动剂的1H-吡唑并[4,3-d]嘧啶化合物 |
KR20220132595A (ko) | 2020-01-27 | 2022-09-30 | 브리스톨-마이어스 스큅 컴퍼니 | 톨-유사 수용체 7 (TLR7) 효능제로서의 C3-치환된 1H-피라졸로[4,3-d]피리미딘 화합물 |
EP4097101A1 (en) | 2020-01-27 | 2022-12-07 | Bristol-Myers Squibb Company | 1h-pyrazolo[4,3-d]pyrimidine compounds as toll-like receptor 7 (tlr7) agonists |
WO2021154666A1 (en) | 2020-01-27 | 2021-08-05 | Bristol-Myers Squibb Company | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS |
US20230131192A1 (en) | 2020-01-27 | 2023-04-27 | Bristol-Myers Squibb Company | 1H-PYRAZOLO[4,3-d]PYRIMIDINE COMPOUNDS AS TOLL-LIKE RECEPTOR 7 (TLR7) AGONISTS |
CN115210235A (zh) | 2020-01-27 | 2022-10-18 | 百时美施贵宝公司 | 作为Toll样受体7(TLR7)激动剂的1H-吡唑并[4,3-d]嘧啶化合物 |
WO2021177679A1 (ko) | 2020-03-02 | 2021-09-10 | 성균관대학교산학협력단 | 병원균 외벽 성분 기반 생병원체 모방 나노 입자 및 그 제조 방법 |
AU2021237718B2 (en) | 2020-03-20 | 2023-09-21 | Gilead Sciences, Inc. | Prodrugs of 4'-C-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same |
CN116057045A (zh) | 2020-06-05 | 2023-05-02 | 金耐特生物制药公司 | 成纤维细胞生长因子受体激酶抑制剂 |
US20230355750A1 (en) | 2020-08-04 | 2023-11-09 | Progeneer Inc. | Kinetically acting adjuvant ensemble |
JP2023536954A (ja) | 2020-08-04 | 2023-08-30 | プロジェニア インコーポレイテッド | 活性化部位が一時的に不活性化したトール様受容体7または8作用薬と機能性薬物の結合体およびその用途 |
WO2022031021A1 (ko) | 2020-08-04 | 2022-02-10 | 성균관대학교산학협력단 | 동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신 |
CN115119508A (zh) * | 2021-01-20 | 2022-09-27 | 上海维申医药有限公司 | 大环tlr7激动剂、其制备方法、药物组合物及其用途 |
EP4316518A1 (en) * | 2021-03-29 | 2024-02-07 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Drug combination of toll-like receptor 7 agonist and anti-pd-l1 antibody |
KR20240006683A (ko) | 2021-05-13 | 2024-01-15 | 길리애드 사이언시즈, 인코포레이티드 | TLR8 조절 화합물과 항-HBV siRNA 치료제의 조합물 |
CA3222439A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
US11926628B2 (en) | 2021-06-23 | 2024-03-12 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
WO2022271684A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
US11932634B2 (en) | 2021-06-23 | 2024-03-19 | Gilead Sciences, Inc. | Diacylglycerol kinase modulating compounds |
CN114409654A (zh) * | 2021-12-30 | 2022-04-29 | 安徽普利药业有限公司 | 一种btk抑制剂的中间体合成方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6028076A (en) | 1996-07-03 | 2000-02-22 | Japan Energy Corporation | Purine derivative |
EP1035123B1 (en) | 1997-11-28 | 2003-08-20 | Sumitomo Pharmaceuticals Company, Limited | Novel heterocyclic compounds |
WO2007024707A2 (en) * | 2005-08-22 | 2007-03-01 | The Regents Of The University Of California | Tlr agonists |
PT2510946E (pt) * | 2007-02-07 | 2015-11-23 | Univ California | Conjugados de agonistas sintéticos de tlr e suas utilizações |
KR101561710B1 (ko) | 2007-06-29 | 2015-10-19 | 길리애드 사이언시즈, 인코포레이티드 | 퓨린 유도체 및 그것의 톨 유사 수용체 7의 조절 인자로서 용도 |
ATE501136T1 (de) | 2007-08-03 | 2011-03-15 | Pfizer Ltd | Imidazopyridinone |
ES2623794T3 (es) | 2008-12-09 | 2017-07-12 | Gilead Sciences, Inc. | Intermedios para la preparación de moduladores de receptores tipo toll |
DE102011008352A1 (de) * | 2011-01-12 | 2012-07-12 | Merck Patent Gmbh | 5-([1,2,3]Triazol-4-yl)-7H-pyrrolo-[2,3-d]pyrimidinderivate |
US9139590B2 (en) * | 2011-02-04 | 2015-09-22 | Duquesne University Of The Holy Spirit | Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient |
EP2674170B1 (en) * | 2012-06-15 | 2014-11-19 | Invivogen | Novel compositions of TLR7 and/or TLR8 agonists conjugated to lipids |
DK2906563T3 (da) * | 2012-10-10 | 2018-06-06 | Janssen Sciences Ireland Uc | Pyrrolo[3,2-d]pyrimidinderivater til behandling af virusinfektioner og andre sygdomme |
RU2640200C2 (ru) | 2012-11-20 | 2017-12-27 | ГЛАКСОСМИТКЛАЙН ЭлЭлСи | Новые соединения |
RS56233B1 (sr) * | 2012-11-20 | 2017-11-30 | Glaxosmithkline Llc | Nova jedinjenja |
CA2890201A1 (en) * | 2012-11-20 | 2014-05-30 | Glaxosmithkline Llc | Novel compounds |
RU2676684C2 (ru) | 2014-02-20 | 2019-01-10 | ГлаксоСмитКлайн Интеллекчуал Проперти (No.2) Лимитед | ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-d]ПИРИМИДИНА В КАЧЕСТВЕ ИНДУКТОРОВ ЧЕЛОВЕЧЕСКОГО ИНТЕРФЕРОНА |
MX2016014308A (es) | 2014-05-01 | 2017-01-27 | Novartis Ag | Compuestos y composiciones como agonistas del receptor tipo toll 7. |
KR102139847B1 (ko) | 2014-05-01 | 2020-07-31 | 노파르티스 아게 | 톨-유사 수용체 7 효능제로서의 화합물 및 조성물 |
CN106661034B (zh) * | 2014-08-15 | 2019-11-29 | 正大天晴药业集团股份有限公司 | 作为tlr7激动剂的吡咯并嘧啶化合物 |
CN105732635A (zh) | 2014-12-29 | 2016-07-06 | 南京明德新药研发股份有限公司 | 一类Toll样受体7激动剂 |
-
2015
- 2015-08-14 CN CN201580041989.3A patent/CN106661034B/zh active Active
- 2015-08-14 PT PT158314518T patent/PT3190113T/pt unknown
- 2015-08-14 UA UAA201702350A patent/UA117634C2/uk unknown
- 2015-08-14 CN CN201911020774.XA patent/CN110938076B/zh active Active
- 2015-08-14 EA EA201790389A patent/EA032824B1/ru unknown
- 2015-08-14 SG SG11201701169XA patent/SG11201701169XA/en unknown
- 2015-08-14 ES ES15831451T patent/ES2875313T3/es active Active
- 2015-08-14 DK DK15831451.8T patent/DK3190113T3/da active
- 2015-08-14 KR KR1020197024042A patent/KR20190098277A/ko not_active Application Discontinuation
- 2015-08-14 HU HUE15831451A patent/HUE054672T2/hu unknown
- 2015-08-14 WO PCT/CN2015/086909 patent/WO2016023511A1/zh active Application Filing
- 2015-08-14 MY MYPI2017700489A patent/MY190026A/en unknown
- 2015-08-14 CA CA2958097A patent/CA2958097C/en active Active
- 2015-08-14 CN CN202110224402.XA patent/CN112898308A/zh active Pending
- 2015-08-14 MX MX2017002028A patent/MX2017002028A/es unknown
- 2015-08-14 KR KR1020177007194A patent/KR102215609B1/ko active IP Right Grant
- 2015-08-14 EP EP15831451.8A patent/EP3190113B1/en active Active
- 2015-08-14 BR BR112017002811-5A patent/BR112017002811B1/pt active IP Right Grant
- 2015-08-14 CN CN201911022725.XA patent/CN110759916B/zh active Active
- 2015-08-14 SG SG10201809918RA patent/SG10201809918RA/en unknown
- 2015-08-14 SI SI201531613T patent/SI3190113T1/sl unknown
- 2015-08-14 US US15/503,977 patent/US9962388B2/en active Active
- 2015-08-14 JP JP2017527961A patent/JP6328341B2/ja active Active
- 2015-08-14 AU AU2015303558A patent/AU2015303558B2/en active Active
- 2015-08-14 PL PL15831451T patent/PL3190113T3/pl unknown
- 2015-08-14 LT LTEP15831451.8T patent/LT3190113T/lt unknown
-
2017
- 2017-02-14 CL CL2017000379A patent/CL2017000379A1/es unknown
- 2017-02-14 IL IL250586A patent/IL250586B/en active IP Right Grant
- 2017-02-15 PH PH12017500281A patent/PH12017500281A1/en unknown
-
2018
- 2018-04-17 US US15/955,523 patent/US10555949B2/en active Active
- 2018-04-17 JP JP2018079330A patent/JP6639551B2/ja active Active
- 2018-06-06 ZA ZA2018/03736A patent/ZA201803736B/en unknown
- 2018-10-01 AU AU2018236899A patent/AU2018236899B2/en active Active
-
2019
- 2019-10-22 AU AU2019253788A patent/AU2019253788C1/en active Active
-
2020
- 2020-07-16 PH PH12020551089A patent/PH12020551089A1/en unknown
- 2020-08-25 IL IL276908A patent/IL276908A/en unknown
-
2021
- 2021-06-09 HR HRP20210927TT patent/HRP20210927T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276908A (en) | Use of pyrrolopyrimidine compounds as an agonist for TLR7 | |
DK3436461T3 (da) | Pyrrolotriazinforbindelser som tam-inhibitorer | |
DK3277677T3 (da) | 1-cyano-pyrrolidinforbindelser som usp30-hæmmere | |
DK3209656T3 (da) | Indolcarboxamidforbindelser, der er anvendelige som kinasehæmmere | |
DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
DK3105218T3 (da) | Cyclopropylaminer som lsd1-inhibitorer | |
DK3105226T3 (da) | Cyclopropylaminer som lsd1-inhibitorer | |
DK3294713T5 (da) | Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer | |
DK3235819T3 (da) | Pyrrolopyrimidinforbindelser, der er anvendelige som JAK-inhibitorer | |
DK3288944T3 (da) | Imidazopyrazinoner som pde1-inhibitorer | |
DK3116475T3 (da) | Dopa-decarboxylasehæmmersammensætninger | |
DK3256462T3 (da) | Substituerede 2-thioimidazolyl-carboxamider som skadedyrsbekæmpelsesmiddel | |
DK3544981T3 (da) | Benzodiazoliumforbindelser som enac-inhibitorer | |
DK3177624T3 (da) | Imidazopyridazinforbindelser | |
BR112016030730A2 (pt) | Composto | |
BR112017013013A2 (pt) | combinações de composto ativo | |
DK3191466T3 (da) | Azetidinyloxyphenylpyrrolidinforbindelser | |
DK3212237T3 (da) | Methotrexatformulering | |
DK3597189T3 (da) | Krystallinske forbindelser | |
DK3319970T3 (da) | Pyrido-oxazinonderivater som tnap-hæmmere | |
DK3233862T3 (da) | Imidazopyridazinderivater som pi3k-beta-inhibitorer | |
DK3233839T3 (da) | Heterocyclylkoblede imidazopyridazinderivater som pi3k-beta-inhibitorer | |
DK3148513T3 (da) | Ceritinib-formulering | |
DK3126354T3 (da) | Halogenerede quinazolin-thf-aminer som pde1-inhibitorer | |
DK3193856T3 (da) | Formulering |